The best Side of ABBV-744 clinical trial phase 1 results
These side effects were notably milder in comparison to an inhibitor of the two bromodomains. An in depth molecular Assessment also uncovered that ABBV-744 preferentially inhibits the expression of Androgen Receptor (AR)-dependent genes. ? Stephen Taylor
Doable new techniques to the diagnos